Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 14/20 | 0.60 |
| ▸ | AR | P10275 | 3/20 | 0.53 |
| ▸ | DDB1 | Q16531 | 3/20 | 0.52 |
| ▸ | BTK | Q06187 | 3/20 | 0.52 |
| ▸ | EGFR | P00533 | 3/20 | 0.48 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.48 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.48 |
| ▸ | IRAK3 | Q9Y616 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | CDK9 | P50750 | 1/20 | 0.47 |
| ▸ | PLK4 | O00444 | 1/20 | 0.47 |
| ▸ | ITK | Q08881 | 1/20 | 0.46 |
| ▸ | HPGDS | O60760 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23117874 | 1.00 | CRBN (0.60) | CRBNARDDB1BTKEGFR | |
| SCHEMBL23134577 | 0.92 | CRBN (0.58) | CRBNARDDB1BTKEGFR | |
| SCHEMBL29596415 | 0.90 | CRBN (0.56) | CRBNARDDB1BTKEGFR | |
| SCHEMBL29822185 | 0.90 | CRBN (0.58) | CRBNARDDB1BTKEGFR | |
| SCHEMBL23117898 | 0.90 | CRBN (0.58) | CRBNARDDB1BTKEGFR | |
| SCHEMBL24299483 | 0.90 | CRBN (0.62) | CRBNARDDB1BTKEGFR | |
| SCHEMBL24299348 | 0.90 | CRBN (0.66) | CRBNARDDB1BTKEGFR | |
| SCHEMBL29986989 | 0.90 | CRBN (0.66) | CRBNARDDB1BTKEGFR | |
| SCHEMBL22661317 | 0.90 | CRBN (0.57) | CRBNARDDB1BTKEGFR | |
| SCHEMBL23117832 | 0.90 | CRBN (0.57) | CRBNARDDB1BTKEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4034114-A1 | NOVEL UREAS HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF | Accutar Biotechnology Inc. (US) | 2022-08-03 | — | — | EP | disclosed |